This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Ironwood Pharmaceuticals Inc (IRWD)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -272.81M -72.62M -64.85M -51.86M
Operating Gains/Losses 610.00K 20.00K 7.00K 474.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -1.73M -835.00K 2.24M 2.32M
(Increase) Decrease in Inventories -11.92M -6.70M 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 2.83M -2.35M
(Decrease) Increase In Payables -11.72M 24.24M 5.09M 2.74M
(Decrease) Increase In Other Current Liabilities -2.25M -1.35M -1.13M -4.26M
(Increase) Decrease In Other Working Capital -8.02M -37.32M -45.81M -17.08M
Other Non-Cash Items 21.55M 17.57M 13.97M 4.56M
Net Cash From Continuing Operations -273.36M -69.63M -75.24M -61.93M
Net Cash From Discontinued Operations 0.00 0.00 0.00 -5.97M
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -273.36M -69.63M -75.24M -67.90M
Sale of Property, Plant & Equipment 0.00 9.00K 4.00K 1.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 196.10M 140.76M 222.25M 236.48M
Purchases of Property, Plant & Equipment -9.59M -13.98M -9.68M -17.22M
Acquisitions 0.00 0.00 0.00 9.50M
Purchases of Short-Term Investments -287.94M -96.71M -97.51M -441.80M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -101.43M 30.08M 115.06M -213.04M
Issuance of Debt 175.00M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 147.06M 89.25M 3.39M 205.19M
Repayment of Long-Term Debt -768.00K -275.00K -260.00K -1.96M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -7.72M 0.00 0.00 0.00
Net Cash From Financing Activities 313.58M 88.97M 3.13M 202.96M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -61.21M 49.42M 42.96M -77.98M

IRWD Ironwood Pharmaceuticals Inc

Analysts Ratings for IRWD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 4 3 3
Moderate Buy 0 0 0 0
Hold 3 3 3 4
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 1

Brokerage Partners

IRWD Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs